Loading organizations...
Key people at QB Capital/NCB Venture Capital.
QBN Capital is a Hong Kong-based venture capital firm specializing in early and growth-stage investments across FinTech and DeepTech in Asia and Europe. The firm targets companies leveraging advanced technologies like artificial intelligence, biometrics, and cybersecurity. Their strategy supports innovative ventures delivering superior solutions, enabling rapid scaling within these technology domains.
The firm's strategic foundation is shaped by experienced leaders such as Frank Tong, a venture capitalist with deep technology and entrepreneurship expertise, including his role at HSBC. QBN Capital was established on the insight that constant technological advancement redefines industries, creating a need for capital to accelerate disruptive solutions.
QBN Capital partners with entrepreneurs and technology companies creating impactful solutions for market challenges. The firm's vision involves investing in a future fueled by continuous innovation. They aim to embrace change, create value for portfolio companies, and accelerate growth, fostering a technologically advanced global society.
QB Capital/NCB Venture Capital has 1 tracked investment across 1 company. The latest tracked deal is $29.0M Series B in LUCA Science in June 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 1, 2022 | LUCA Science | $29.0M Series B | 4BIO Capital, Shuntaro Kodama | Astellas Venture Management, Axil Capital, Mogrify, Parkwalk Advisors, Remiges Ventures, Sana Capital, Jonathan Milner, Asahi Kasei Pharma, Nippon Venture Capital, Nissay Capital, SMBC Venture Capital |
Key people at QB Capital/NCB Venture Capital.
